Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy
- 作者S. Shukla; A. Shukla; S. Mehboob; S. Guha
- 卷第33卷
- 期第6期
- 印刷ISSN0269-2813
- 电子ISSN1365-2036
- 文件大小274.01KB
- 发表时间2011
- DOI10.1111/j.1365-2036.2010.04574.x
- 页码662-671
The challenge of acute rejection in intestinal transplantationE. Y. Yoshitoshi, A. Yoshizawa, E. Ogawa, M. Kaneshiro, N. Takada, S. Okamoto, Y. Fujimoto, S. Sakamoto, S. Masuda, M. Matsuura, Y. Nakase, T. Chiba, T. Tsuruyama, H. Haga, S. Uemoto · 2012
Tacrolimus: rescue therapy or experimental drug for severe ulcerative colitis?H. Nakase; S. Yamamoto; M. Matsuura; T. Chiba · 2011
Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitisS. YAMAMOTO; H. NAKASE; S. MIKAMI; S. INOUE; T. YOSHINO; Y. TAKEDA; K. KASAHARA; S. UENO; N. UZA; H. KITAMURA; H. TAMAKI; M. MATSUURA; K. INUI; T. CHIBA · 2008
Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimusH. Nakase; S. Yamamoto; M. Matsuura; Y. Honzawa; T. Chiba · 2010
The effect of proteasome inhibitor MG132 on experimental inflammatory bowel diseaseS. Inoue; H. Nakase; M. Matsuura; S. Mikami; S. Ueno; N. Uza; T. Chiba · 2009
Tacrolimus suppresses IL-12/IL23 p40 in Crohn’s disease and heals fistulae refractory to anti-TNF-α therapyH. Nakase; M. Matsuura; N. Uza; T. Chiba · 2011